why am i gaining weight on glp 1 GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Loss and Obesity Weaning off a GLP-1? Tips

Privacy and Security Requirements HIPAA Compliance (Federal): All telehealth providers must: Protect patient health information Use secure, encrypted platforms Have privacy policies Obtain patient consent Report breaches State Privacy Laws: Some states have additional requirements: California (CCPA) Virginia (VCDPA) Other state-specific privacy laws Legitimate providers: Use HIPAA-compliant video platforms Secure messaging systems Encrypted data storage Clear privacy policies BAA (Business Associate Agreements) with partners State-Specific Examples Texas: Allows asynchronous consultations Provider must be licensed in Texas Relatively permissive telehealth laws Large telehealth market New York: May require more documentation Stricter telemedicine regulations Video consultation often preferred over asynchronous TrimRx serves New York with compliant processes California: Robust telehealth infrastructure Provider licensing required Generally permissive for GLP-1s Large market for telehealth services Florida: Allows telehealth for weight loss Provider must be Florida-licensed Relatively straightforward regulations Arkansas: More restrictive telehealth laws historically May have additional requirements Fewer providers serve Arkansas How to Check Your State: Verify Telehealth Access: Check provider website for state coverage list State boards of medicine often have telehealth info Ask provider directly about state regulations Confirm during consultation process Most states allow GLP-1 prescribing via telehealth, but specific requirements vary

They are released throughout the day, increasing at mealtimes, and have several functions: Stimulate the production and secretion of insulin in response to eating (glucose-dependent insulin secretion) GLP-1 enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion Slow digestion and decrease appetite Thus, DPP-4 inhibitors indirectly enhance insulin release, suppress glucagon secretion, and improve glycaemic control

Cornell and Numerators report stated: "Overall, the results show that GLP-1 users reduce spending on high-calorie, high-sugar or high-fat items

Roy S, Ghosh A (2019) Significant Reduction of Elevated Triglycerides and Liver Fibrosis in Diabetic Dyslipidemia with Saroglitazar: A Case Report

Thyroid cancer fears were exacerbated by reports from the U.S

doi: 10.3810/pgm.2012.11.2613